Accueil › Cancer de la prostate › Caroline du Nord › Durham
Essais cliniques pour Cancer de la prostate à Durham, NC
32 études pour Cancer de la prostate recherchent des participants dans et autour de Durham (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Recrutement en coursPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
DESTINY-PANTUMOUR04
Recrutement en coursÉtude observationnelle
- Research Site, Durham
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Recrutement en coursPhase 1/2
- Duke University Medical Center, Durham
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Recrutement en coursPhase 3
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke Cancer Center, Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- et 1 autres
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Recrutement en coursPhase 2
- Durham VA Medical Center, Durham, NC, Durham
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Recrutement en coursPhase 2
- Durham VA Medical Center, Durham, NC, Durham
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Recrutement en coursPhase 1
- Duke University Medical Center, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- Duke University, Durham
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Recrutement en coursPhase 3
- Duke University Medical Center, Durham
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Recrutement en coursPhase 3
- Durham VA Medical Center, Durham
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Recrutement en coursPhase 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
The Vanguard Study: Testing a New Way to Screen for Cancer
Recrutement en coursVolontaires sains bienvenus
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Durham VA Medical Center, Durham
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Recrutement en coursPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Recrutement en coursÉtude observationnelle
- Duke University, Durham
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Recrutement en coursPhase 1
- Duke University Medical Center, Durham
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Recrutement en coursPhase 1/2
- Duke University medical center, Durham
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recrutement en coursPhase 2
- Duke University Medical Center - Duke Cancer Center, Durham
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Duke University, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Recrutement en coursPhase 1
- Duke Cancer Institute, Durham
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
Recrutement en coursÉtude observationnelle
- Duke University, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Recrutement en coursPhase 1
- Duke Cancer Center, Durham
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Recrutement en coursPhase 1/2
- Duke University, Durham
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Recrutement en coursVolontaires sains bienvenus
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · à 10 mi
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Recrutement en coursPhase 4
- Duke University Medical Center, Durham
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Recrutement en coursÉtude observationnelle
- Durham VA Medical Center, Durham
- Duke Cancer Network, Durham
- Duke University, Durham
- et 1 autres
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Recrutement en coursPhase 2/3
- Durham VA Medical Center, Durham, NC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recrutement en coursPhase 1
- Duke Cancer Institute, Durham
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Recrutement en coursPhase 1
- Duke Cancer Center, Durham
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Recrutement en cours
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Chapel Hill · à 10 mi
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Recrutement en coursÉtude observationnelle
- Duke University Medical Center, Durham
Essais pour Cancer de la prostate dans d'autres villes
- New York City, NY103 études
- Houston, TX76 études
- Los Angeles, CA61 études
- Boston, MA60 études
- St. Louis, MO47 études
- San Francisco, CA45 études
- Chicago, IL45 études
- Seattle, WA44 études
- Philadelphia, PA44 études
- Nashville, TN43 études
- Baltimore, MD42 études
- Washington, DC38 études
Autres études à Durham
- Cancer du sein63 études
- Cancer (tous types)59 études
- Cancer du poumon non à petites cellules39 études
- Myélome multiple37 études
- Cancer métastatique33 études
- Leucémie aiguë myéloïde33 études
- Cancer du poumon32 études
- Cancer colorectal28 études
- Cancer de l'ovaire27 études
- Leucémie lymphocytaire chronique27 études
- Insuffisance cardiaque26 études
- Cancer du pancréas25 études
Source : ClinicalTrials.gov, données récupérées le 1 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.